🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12381+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12381 recruiting trials

Phase 1, PHASE2RecruitingNCT06137144

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

🏥 AstraZeneca📍 33 sites📅 Started Jan 2024View details ↗
RecruitingNCT07516886

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

👨‍⚕️ Daimantas Milonas, MD, PhD, Professor, Lietuvos sveikatos mokslų universitetas📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06023862

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

👨‍⚕️ JUNGYUN LEE, Ph.D., Severance Hospital, Yonsei University Health System📍 18 sites📅 Started Jan 2024View details ↗
NARecruitingNCT05937789

Early Vitamin D3 Supplementation for Critically Ill Patients

🏥 National Taiwan University Hospital📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06043674

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

👨‍⚕️ Christine Ryan, MD, Dana-Farber Cancer Institute📍 5 sites📅 Started Jan 2024View details ↗
RecruitingNCT06397677

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

👨‍⚕️ Joyce S Lee, University of Colorado, Denver📍 4 sites📅 Started Jan 2024View details ↗
NARecruitingNCT05702749

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

👨‍⚕️ Michael Harris, MD, Medical College of Wisconsin📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05903742

Standardising Care for Hepatitis Delta in the Netherlands

🏥 Erasmus Medical Center📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06096675

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

👨‍⚕️ Jai Singh, MD, Wake Forest University Health Sciences📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05936073

DELTA DESCRIBE: the French Collaborative Project

👨‍⚕️ Véronique Loustaud-Ratti, Pr, University Hospital, Limoges📍 1 site📅 Started Jan 2024View details ↗
Enrolling by InvitationNCT06261333

Quality of Life in Patients With Hemorrhagic Telangiectasia

🏥 University Hospital, Essen📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06305234

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

👨‍⚕️ Medical Director, MD, BioMarin Pharmaceutical📍 6 sites📅 Started Jan 2024View details ↗
RecruitingNCT06111612

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

👨‍⚕️ Xianmin Song, MD, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06203249

Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease

🏥 Chinese PLA General Hospital📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT05641844

A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas

🏥 RedDress Ltd.📍 10 sites📅 Started Jan 2024View details ↗
RecruitingNCT06207812

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

👨‍⚕️ Julia Dai, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2024View details ↗
Phase 1, PHASE2RecruitingNCT06249919

A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

👨‍⚕️ Joseph Park, M.D., Neuracle Science📍 16 sites📅 Started Jan 2024View details ↗
Phase 2, PHASE3RecruitingNCT06120049

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD

👨‍⚕️ Koen Van Laere, Professor at KULeuven, department head of nuclear medicine at UZ Leuven📍 2 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06208462

Neoadjuvant Therapy of HAIC(GEMOX) Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

👨‍⚕️ Feng Cheng, MD, The First Affiliated Hospital with Nanjing Medical University📍 3 sites📅 Started Jan 2024View details ↗
Phase 3RecruitingNCT06345365

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

👨‍⚕️ Fuling Zhou, Wuhan University📍 11 sites📅 Started Jan 2024View details ↗
← PreviousPage 335 of 620Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →